The prostacyclin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Prostacyclin drugs are used to treat pulmonary arterial hypertension (PAH), a disease in which the arteries that convey deoxygenated blood from the heart to the lungs have excessive blood pressure. PAH prostacyclin analogs are synthetic versions of prostacyclin, […]
